OBJECTIVES: Lung cancer invading beyond the interlobar pleura, classified as T2a in the new TNM, is a rare entity with a poor outcome. Our purpose was a better understanding of the mechanisms of this particular behaviour and its prognostic value.
INTRODUCTION
Contrary to non-small cell lung cancer (NSCLC) invading the visceral pleura classified as T2 and NSCLC invading the parietal pleura as T3, NSCLC invading beyond interlobar pleura (interlobar invasion, ILI) was not considered in the international staging system of 1997 [1] . Information in the literature is scarce: some authors suggest that ILI should be categorized as T2 [2, 3] and some others consider it as T3 [4, 5] . It was admitted to classify it as T2a in the new TNM classification [6] . Anyhow, this rare entity represents an NSCLC with a poorer outcome. The purpose of our study was to better understand the reasons that may explain this particular behaviour and its prognostic value and why an ILI tumour is deserved a specific T status.
PATIENTS AND METHODS
The clinical records of patients who underwent surgery for NSCLC between January 1984 and December 2007 in Georges Pompidou European Hospital (Paris) and Cedar Surgery Centre (Boisguillaume) were analysed. The data had been collected prospectively. The pre-operative workup included chest X-ray, bronchoscopy, computed tomography scan of the chest, spirometry, lung perfusion scan and a thorough search for distant metastases (including positron emission tomography scan in recent years). Mediastinoscopy was performed to exclude N3 disease and to confirm N2 involvement in patients included in various neoadjuvant treatment protocols depending on demand of different referring centres. N3 disease and distant metastases precluded surgery. The staging system was the International Staging System for NSCLC adopted in 1997 [1] , and recently modified concerning the T [6] : considering the visceral pleura, a tumour that fell short of completely traversing the elastic layer was defined as PL0, one that extended through the elastic layer as PL1 and one extending to the surface of the visceral pleura as PL2. Patients with T2 bronchial, T3 and T4 lesions were excluded as well as patients who underwent an exploratory thoracotomy or an incomplete resection. The remaining patients (PL0, PL1, PL2 and R0) form the basis of our study. We considered three groups for comparison, whatever the size of the tumour (1-70 mm): group 1 = tumours invading the lobar fissure (ILI), group 2 = tumour within the lung PL0 and group 3 = tumour invading the visceral pleura (PL1 + PL2).We more particularly analysed the pathology, and prognosis characteristics of these patients. The study was approved by our Thoracic Surgery Society Ethic Committee that waived need for informed consent.
Follow-up information was obtained from the hospital case records, from a questionnaire completed by the chest physician or general practitioner, or from death certificates. The main outcome was the overall survival, defined as the time interval between the date of operation and the date of death or the last follow-up visit for censored patients. The mean follow-up duration was 72.8 (±48) months. Actuarial survival curves were estimated by the KaplanMeier method. Statistical comparisons between survival distributions were made using the log-rank test. Multivariate analysis was performed using the Cox proportional hazards model for overall survival analysis. Univariate analysis used the following outcome variables: gender, age, type of surgical resection, histology, type of N involvement and R. For mediastinal LN involvement the classification of Mountain and Dresler [7] was used.
All data analyses were conducted with the two-sided test: a P < 0.05 was considered as statistically significant. The statistical software used for the analysis was SEM (Anticancer Centre Jean Perrin, Clermont-Ferrand, France) [8] .
RESULTS
The entire population consisted of 3316 patients [(male = 2517 (80.8%), female 598 (19.2%)] whose mean age was 61.7 ± 10 year: there was no difference between groups. There were 154 patients in group 1, 2310 in group 2 and 651 in group 3. Main pathological characteristics are given in Table 1 . In the case of ILI (group 1), a pneumonectomy was necessary in 55.2% of cases and a bilobectomy in 19.5%. N-involvement was present in 55.8% of patients, which was significantly more important than in groups 2 and 3, and the frequency of N1 involvement was significantly higher (29.2%). In the case of N0, the frequency of pneumonectomy dropped to 32.4%, and that of bilobectomy rose to 35.3% in group 1, which was still significantly more important than in groups 2 and 3 ( Table 2 ). ILI was observed in the right lung in 65.6% of patients (101/154), whereas involvement of the right lung was 53 and 55.6% in groups 2 and 3 patients (1224/2310 and 362/651, respectively), a highly significant difference between the right and the left side, P = 0.007. The mean size of the tumour in group 1 was 42.7 ± 12 mm, generally bigger than in both other groups, and the frequency of tumours 3 cm or less in diameter in group 1 was 1.9% (29/1558) and that of tumours 3.1-7 cm was 8% (125/1558). The number of adenocarcinoma was not different in groups 1 and 2 but very high in group 3 of tumours with pleural invasion (Table 1) .
Post-operative mortality of the whole population was 3.5% (110/3116): 5.2% (8/154) in group 1, 3.5% (81/2310) in group 2 and 3.2% (21/651) in group 3; P = 0.49. Mortality during the 90 post-operative days was: 7.1% (11/154) in group 1, 5.6% (129/ 2310) in group 2 and 5.7% (37/651) in group 3; P = 0.73. This ; group 3, 24.1 and 9.4%; P = 0.10). However, outcome was poorer in group 1 in the case of pN0, P = 0.0057 (Fig. 1 ), but the difference was not significant between groups 1 and 3 (P = 0.36). There was no difference in survival among groups between NSCLC affecting the right or left lung. Five-year survival rates were not different between groups for tumours 30 mm or less in diameter (43.4, 56.1 and 51.6% for groups 1,2 and 3, respectively; P = 0.13). For tumours measuring between 31 and 70 mm, survival rate was 37.9% in group 1, 48.1% in group 2 and 38.4% in group 3 (P = 0.0024): however, difference between groups 1 and 3 was not significant (P = 0.65). Pneumonectomy was a poor prognostic factor in comparison with the other resections, whatever the group (Table 3) , but there was no significant difference in group 1 between 5-year survival of bilobectomy (n = 29) and pneumonectomy (n = 85), (37.9 versus 34.7%, respectively). Survival rates between groups 1 and 3 were also similar. Multivariate analysis confirmed ILI to be an independent factor of poor prognosis, far behind age, N involvement, histology, pneumonectomy, gender and size of the tumour. Its prognostic value was not different from that of visceral pleura involvement (Table 4) .
COMMENTS
The frequency of ILI is different from one series to the other, ranging from 2.1% [4] to 15.5% [3] , 17.1% [9] , and 17.6% [7] of patients operated in view of cure. It depends on the criteria of patient selection. It was 4.6% in our series from which we excluded T3 and T4 patients, whereas Joshi et al. [7] excluded patients who underwent pneumonectomy and T1 patients, who are not negligible. In any case, the frequency remains low in comparison with tumours invading the visceral pleura for instance (4.6 versus 20.9% in our series). The opportunity for a peripheral NSCLC to invade the fissure depends on its location within the lung and the anatomy. Thus, there is more chance to observe ILI on the right (as in our series) where there are two fissures. On the contrary, the interlobar fissures have anatomical differences in completeness which varies in each individual and the ILI may be misinterpreted, in case of partially complete fissure.
Nonaka et al. [3] found more squamous cell carcinomas in the case of ILI (56 versus 28% of adenocarcinomas). Such difference was not mentioned by others [7, 9] , and there was no difference in our series either (Table 1) , except when comparing groups 1 and 3: more adenocarcinomas were observed in group 3 (60.8%), and more squamous cell carcinomas in group 1 (50 versus 25.8%). Our hypothesis is that adenocarcinomas are more are the more peripheral tumours that which can generate more visceral pleural involvement all over the lung, and squamous cell carcinomas are more often central, and could preferentially be more in the vicinity of the fissures.
We observed that the mean size of ILI tumours was 42.7 ± 12 mm, consisting of 18.8% tumours measuring 30 mm or less in diameter (T1 tumours) and 81.2% of tumours measuring between 31 and 70 mm (T2 tumours). On the other hand, 55.1% of tumours in group 2 and 39.5% of tumours in group 3 were 30 mm or less (Table 1) . Nonaka et al. [3] found similar results, 22% of their ILI tumours were <30 mm and 78% were >30 mm. In fact, the greater the size, the greater is the risk of their invading through the fissure. In the case of a complete fissure, a peripheral tumour invades the visceral pleura of the lobe from which it originates (thus being T2 whatever its size) before invading the visceral pleura of the adjacent lobe, and the T2 status related to visceral pleura invasion may last a long time before invasion of the adjacent lobe. When the adjacent lobe is invaded, whatever the fissure completeness, the T factor is measured only by the size of the tumour in the TNM classification, not considering the previous visceral pleura invasion any longer. It means that a tumour of 1 cm in size is still considered T1 despite reaching both visceral pleurae through the interlobar fissure. However, this eventuality is rare as we observed, probably because the tumour needs to be larger to have more chance of invading through the fissure. Independently, the large size of NSCLC per se is a well known factor of poorer prognosis, and tumours >7 cm are now classified as T3 [6] . The reason for which the size is an independent factor of poor prognosis is not yet completely understood.
The important N-involvement is a particular characteristic of lung cancer with interlobar pleural invasion. The pN2 involvement is very important, but, the pN1 still more in our series ( pN2 = 26.6% and pN1 = 29.1%). This pattern of lymphatic spread is reported by all the authors (Table 5) , and pN0 is commonly inferior to 50% of cases, whereas pN1 is present in more than two-third of patients. Once the adjacent lobe is invaded, the tumour eventually may drain into the adjacent lobe lymphatic system and the pN1 may be due to direct other lobe lymphatic invasion: in effect, we observed that pN1 was also more frequent in bronchial T3 NSCLC which like ILI are central tumours and more often squamous cell carcinomas [10] . The pN2 was more Figure 1 : Long-term survival in pN0 patients: outcome was poorer in group 1 (curve 2), P = 0.0057, but the difference was not significant between groups 1 and 3 (curve 1), P = 0.36, t(m) = time in months. frequent than the pN1 involvement in group 3, which was also reported by Miura et al. [2] who found 30% of pN2 and 13.3% of pN1 in case of visceral pleura involvement. In such case, cancer cells exfoliate from the visceral pleura and disseminate in the pleural cavity where they are reabsorbed by the parietal pleural and diaphragmatic lymph vessels towards the mediastinal lymph nodes and/or the blood circulation [11] , which may explain the worse outcome in initial stages commonly recognized nowadays [12] , and the importance of N-involvement in advanced stages.
The great pneumonectomy requirement (55.2% of our resections, and 66.6% (40/60) of the patients of Demir et al. [9] ), reflect the seriousness of ILI-NSCLCs. The need for pneumonectomy was the consequence of the already discussed pathological characteristics, which are the pN1 and pN2 involvement, and the size of the tumour and its central location. In the more recent work on that topic, Joshi et al. [7] excluded patients who underwent a pneumonectomy from their study because pneumonectomy is associated with a 'higher operative mortality' and 'more proximal and extensive tumour characteristics', which is not justified in our opinion. Patients who underwent pneumonectomy had lower 5-year survival rates not only in ILI-tumours but also in both other groups of our series (Table 3) , and in the case of ILI-tumours, survival rates of pneumonectomy were the same as those of bilobectomy. Pneumonectomy was associated with significant inferior survival in groups 2 + 3, but not in group 1 (Table 3) . Such a frequency was questionable and difficult to explain. However, survival rates were not different between pneumonectomy and bilobectomy in group 1 but also in group 3. The prognostic value of pneumonectomy was not related to the type of resection itself as being a 'dangerous operation', but to the size of the tumour, the high rate of lymph node metastasis and/or its invasion beyond the visceral pleura requiring such extensive resection. We agree that considering such tumours as T2b or T3 is relevant when they are N0, but we believe that it is still not enough when considering the real significance of its prognostic value in the evolution of the disease, which remains the main question to address.
In conclusion, tumours extending across the fissure have a significant effect on long-term survival not only in the primary stages of lung cancer but also in other stages because of their rapid locoregional spread. The prognostic value of the ILI-tumour is underestimated as that of all tumours invading the pleura anywhere [13] , and the role of pleural involvement in any type of lung cancer dissemination is worth of being clarified by further research.
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